Trial Profile
Effect of Single-Pill Combination of Valsartan/Amlodipin in essential hypertension patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Dec 2015
Price :
$35
*
At a glance
- Drugs Amlodipine/valsartan (Primary)
- Indications Essential hypertension
- Focus Therapeutic Use
- Sponsors Novartis
- 12 Dec 2015 New trial record